Doc Admits Letting Aegerion See Patient Data, Target Teens
A pediatric cardiologist helped Aegerion Pharmaceuticals Inc. target dozens of his teenage patients with heart conditions for an expensive medication approved only to treat an ultra-rare disease that none of them...To view the full article, register now.
Already a subscriber? Click here to view full article